Actually ADHD | Medication Strategies & Clinical Wisdom17 Kesä

ADHD Medication Optimization for Adults

The Optimization Blueprint — the algorithm Jonathan Murphy, PMHNP-BC, uses to find the right medication and the right dose for adults with ADHD.

This episode is for two audiences simultaneously: clinicians refining their adult ADHD prescribing practice and patients trying to understand whether their current treatment is optimized.

This episode covers:

The three medication categories: methylphenidate, amphetamine, and non-stimulant
Why extended-release stimulants are first-line and why the "controlled substance" framing misleads prescribers
The standard adult starting doses for the major medications
The response and toleration framework for assessing the first prescription
When to start with amphetamine versus methylphenidate based on presentation
Why methylphenidate is often the better starting point despite being less culturally familiar
What "optimized" actually means: all good, no bad, no side effects, works like a vitamin
The risk of dysfunctional medication relationships and how they form
Why providers who haven't developed comfort with adult ADHD prescribing should consider referring out rather than under-treating

This is the second episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(15)

ADHD Medication Generic Drug Problems & Shortages

How to actually navigate the current ADHD medication shortage and the generic manufacturing variability underneath it. Jonathan Murphy, PMHNP-BC, walks through what the Reddit narrative gets wrong, wh...

3 Elo 16min

Extended Release Stimulants for ADHD | Side Effects Ride Out or Bail?

The Ride Out or Bail framework for the first month on an extended-release ADHD stimulant. Jonathan Murphy, PMHNP-BC, reads from The Process and walks through the eight most common side effects, week b...

28 Heinä 7min

Vyvanse is the OVERHYPED (but still might be right for you)

Why Vyvanse became the internet's favorite ADHD medication and what patients and prescribers should actually understand about it. Jonathan Murphy, PMHNP-BC, walks through the pharmacology, the Reddit ...

25 Heinä 13min

ADHD Reddit, Groupthink and the Guanfacine Controversy

Why guanfacine keeps getting mistaken for a first-line ADHD medication. Jonathan Murphy, PMHNP-BC, walks through the clinical reality of guanfacine, the Reddit dynamics that promoted it, and the group...

20 Heinä 12min

Friction and Flow Talk

Jonathan Murphy, PMHNP-BC, returns to the Focus Path YouTube channel with the 101st video and processes the launch of the Friction video — the underlying formula for building capacity, the medium-is-t...

10 Heinä 12min

Creating the Focus Path YouTube Channel

Creating the Focus Path YouTube Channel. Jonathan Murphy, PMHNP-BC, reflects on the first 100-video sprint of the Focus Path YouTube channel — the market gap that made the work necessary, the YMYL sup...

2 Heinä 8min

ADHD, Trauma, and Developmental Healing

ADHD, Trauma, and Developmental Healing. Jonathan Murphy, PMHNP-BC, tells the origin story of Developmental Reinforcement Theory and the survival modalities, tracing the clinical, personal, and intell...

30 Kesä 15min

ADHD Clinical Accountability on LinkedIn

A Practical ADHD Clinician's Perspective. Jonathan Murphy, PMHNP-BC, drops the filter and speaks directly to peer clinicians about bias, deskilling, the OCPD differential, the patently false claim tha...

25 Kesä 11min